Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
07/2003
07/10/2003US20030130178 Water soluble paclitaxel dervatives
07/10/2003US20030130170 Water soluble paclitaxel derivatives
07/10/2003US20030129223 Therapeutic agents, comprising a linking carrier, a therapeutic entity associated with the linking carrier, and atleast one targeting entity
07/10/2003US20030129191 Radiolabeled biotin and derivatives/conjugates bind hepatocyte receptors; anticancer agents; drug delivery
07/10/2003US20030129136 Complexing; binding epitopes to surfaces; imaging; detection thrombosis, infections, cancer; acoustic reflection
07/10/2003US20030129133 PACAP compositions and methods for tumor imaging and therapy
07/10/2003US20030129131 Using isotopes labeled compound
07/10/2003US20030129130 Drug delivery; microparticles immobilized on polymer surface
07/10/2003CA2469946A1 Dendritic poly (amino acid) carriers and methods of use
07/10/2003CA2468081A1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
07/09/2003EP1325917A1 Radiolabelled alkylamino-benzothiazole and -benzoxazole derivatives and their use as D4 ligands
07/09/2003EP1325028A2 New inhibitors of iapp fibril formation and uses thereof
07/09/2003EP0686260B1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
07/09/2003CN1113881C 8-substituted-1,3,8-triaza-spiro [4.5] decan-4-on derivatives
07/08/2003US6589981 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives
07/08/2003US6589504 Binding or aggregating fibrils with radiolabeled quinoline-hydrazone compound
07/08/2003US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
07/08/2003US6589502 Radioisotope dispersed in a matrix for brachytherapy
07/08/2003CA2095615C Polyazamacrocyclic compounds for complexation of metal ions
07/03/2003WO2003053509A2 Radioactive ion
07/03/2003WO2003053328A1 Composition comprising marked befloxatone
07/03/2003WO2002076497A3 Method and composition
07/03/2003US20030125283 Drug delivery by administing a radioactive material tritium to target cell nuclei, emitting a low-energy beta ray to damage the cell; radiotherapy
07/03/2003US20030124120 Quinolone vitronectin receptor antagonist pharmaceuticals
07/03/2003US20030124059 Imaging agents, precursors thereof and methods of manufacture
07/03/2003US20030124058 Immunotherapy of B-cell malignancies using anti-CD22 antibodies
07/03/2003US20030124056 Carrier molecules
07/03/2003US20030124055 Immobilization to polymer; antitumor agents, rheumatic diseases, autoimmune disease
07/03/2003US20030124054 Antitumor agents; anticancer agents; viricides
07/03/2003US20030124053 Radiopharmaceuticals for imaging infection and inflammation
07/03/2003CA2470006A1 Radioactive ion
07/02/2003EP1322769A2 Protein phosphatases
07/02/2003EP1322653A2 Metal complexes for use in medical and therapeutic applications
07/02/2003CN1427728A Preparation for evaluating eliminative ability of stomach
07/01/2003US6586404 Pharmaceutical preparations of glutathione and methods of administration thereof
07/01/2003US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization
07/01/2003US6586008 For delivery to the pulmonary system; particles consist of a therapeutic, prophylactic or diagnostic agent, or any combination thereof, an amino acid or salt thereof, and a phospholipid or combination of phospholipids
07/01/2003US6585953 Fluorinating a 17F-labeled F2 with an alkane, a substituted or unsubstituted alkene, or a substituted or unsubstituted alkyne in the presence of a metal oxide, especially silver oxide, catalyst
07/01/2003US6585632 Device for conveying radioactive agents on angioplasty stents, respective method and kit
06/2003
06/26/2003WO2003051859A1 Compounds for imaging alzheimer's disease
06/26/2003WO2003051403A1 Treatment of osteomyelitis with radiopharmaceuticals
06/26/2003WO2003051395A2 Edg-receptor agonist for the treatment of hypertension
06/26/2003US20030120355 Biocompatible and biodegradable polymers for diagnostic and therapeutic radioisotope delivery
06/26/2003US20030120046 99m technetium, 188 and 186 rhenium chelated to 1-thio-d-glucose, glucosamine, or salts and hydrates thereof; tumor imaging agents
06/26/2003US20030119844 Bind with high selectivity and/ or high affinity to CRF1 receptors (Corticotropin Releasing Factor 1 Receptors), useful for treating psychiatric and neurological diseases, including depression, anxiety and post trauma stress
06/26/2003US20030119719 Use of endothelin conjugates in therapy, new endothelin conjugates, agents that contain the latter, and process for their production
06/26/2003US20030118595 Supramolecular bioconjugates
06/26/2003US20030118594 Stable formulations of mhc-peptide complexes
06/26/2003US20030118553 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and metastases mediated thereof
06/26/2003US20030118508 Treatment of osteomyelitis with radiopharmaceuticals
06/26/2003US20030118507 Methods of using 46828, a human acyl-CoA synthetase
06/25/2003EP1321155A2 Polymer-coated stents, methods for preparing same and their use for restenosis prevention
06/25/2003EP1320549A2 Pumpcn compositions and uses thereof
06/25/2003EP1320355A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
06/25/2003EP0618969B1 Composite antibodies of human subgroup iv light chain capable of binding to tag-72
06/25/2003CN1426307A 蛋白质 Protein
06/25/2003CN1112178C Sustained release and implantion type methotrexate medicine and method for preparing same
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/19/2003WO2003050499A2 Use of a labeled ligand having human cd4 specificity
06/19/2003WO2003049804A2 Treatment of genitourinary tract disorders
06/19/2003US20030114518 A conjugated drug with polyamideether copolymer including polylactams and polyether; nontoxic, drug delivery, sustained release
06/19/2003US20030114453 Antiinflammatory agents; asthma; skin disorders
06/19/2003US20030114397 Water soluble paclitaxel derivatives
06/19/2003US20030114363 Water soluble paclitaxel derivatives
06/19/2003US20030113872 Vasopermeability-enhancing conjugates
06/19/2003US20030113336 A compound comprising a targeting moiety binds to a chelator, quinolone antibiotics, imaging tumors in a patient, treating cancer
06/19/2003US20030113335 A conjugate molecule comprising an antitumor drug, a polyglutamate polymer and a targeting molecule; antitumor agents, treating autoimmune disorders such as rheumatoid arthritis, restenosis prevention
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
06/19/2003US20030113262 Gpib-lipid bond construct and use thereof
06/19/2003US20030113261 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system
06/19/2003CA2469901A1 Use of a labelled ligand having specificity for the human cd4 molecule to produce a diagnostic agent for analysing migration and/or distribution patterns of cell populations
06/18/2003EP1318982A1 Compounds and methods for diagnosing and treating amyloid-related conditions
06/18/2003EP1263477A4 Simultaneous multimodal measurement of physiological function
06/18/2003EP0920623B1 Boron neutron capture therapy using pre-targeting methods
06/17/2003US6580016 Attaching a biocompatible lipid avid agent to a lipid accumulation in a wall of the artery; predicting rupture; atherosclerosis diagnosis
06/17/2003CA2046654C Radiolabeled proteins for diagnostic or therapeutic use
06/12/2003WO2003048765A1 Breath test
06/12/2003WO2003048328A2 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
06/12/2003WO2003048306A2 Polycistronic expression of antibodies
06/12/2003WO2003048200A1 Nuclear protein 'shoca' - a component of the wnt signalling pathway
06/12/2003WO2003047553A1 Synthesis of small particles
06/12/2003WO2001073133A9 Compositions and methods for identifying and targeting cancer cells
06/12/2003US20030108486 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules
06/12/2003CA2469356A1 Nuclear protein "shoca" - a component of the wnt signalling pathway
06/12/2003CA2467738A1 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
06/12/2003CA2467363A1 Polycistronic expression of antibodies
06/11/2003EP1317268A2 Targeted alpha particle therapy using actinium-225 conjugates
06/11/2003EP0810855B1 Polyalkylene block copolymers as surface modifiers for nanoparticles
06/11/2003EP0782863B1 Antibody reagent for detecting dissecting aortic aneurysm and use thereof
06/11/2003CN1423658A Modulation of human sodium channels in dorsal root ganglia
06/10/2003US6576793 β2-adrenergic receptor agonists
06/10/2003US6576746 Site-specific labeling of disulfide-containing targeting vectors
06/10/2003US6576222 Complex stability and specificity; NMR contrast media as diagnostic aid for localization of vascular disease
06/10/2003US6575888 Bioabsorbable brachytherapy device
06/10/2003CA2030472C Cascade polymer bound complexing compounds their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
06/05/2003WO2003046930A1 Processes for producing 15o-carbon monoxide and 15o-carbon dioxide and production apparatus
06/05/2003WO2003045940A2 Benzazepine derivatives and their use as 5-ht ligands
06/05/2003WO2003045546A1 The use of metal-chelating adsorbents
06/05/2003WO2003020106A3 Composite staple for completing an anastomosis
06/05/2003WO2002060485A3 Use of immunoregulatory antibodies in the treatment of neoplastic disorders
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 243